Table 1.
Design of the randomized, balanced cross-over design according to the condition (curcumin + piperine versus placebo) and the legs (dominant versus non-dominant).
First session
Second session
Group 1
Dominant leg–curcumin + piperine
Nondominant leg– placebo
Group 2
Non dominant leg–curcumin + piperine
Dominant leg– placebo
Group 3
Dominant leg– placebo
Nondominant leg– curcumin + piperine
Group 4
Nondominant leg– placebo
Dominant leg–curcumin + piperine